COMMUNIQUÉS West-GlobeNewswire

NewCelX Management to Attend Breakthrough T1D Congress in Philadelphia, Advancing Its Mission to Develop a Cure for Type 1 Diabetes
28/09/2026
Following successful FDA Pre-IND meeting, NewcelX advances IND-enabling activities for NCEL-101 ZURICH, Sept. 28, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. (Nasdaq: NCEL), a regenerative medicine company developing stem- [...]
Callio Therapeutics Appoints Chris Hassig, PhD, as Chief Scientific Officer
28/09/2026
Industry veteran brings more than two decades of oncology drug discovery leadership to advance Callio's dual-payload ADC pipeline SAN DIEGO and SEATTLE and SINGAPORE, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Callio [...]
ORYZON Receives European Medicines Agency Approval to Initiate the HOPE-2 Phase II Study of Vafidemstat for the Treatment of Phelan-McDermid Syndrome (PMS)
28/09/2026
PMS is a severely disabling genetic disorder related to autism U.S. prevalence is estimated at approximately 1 in 7,300 people HOPE-2 is partially funded through Oryzon’s VANDAM project under Med4Cure, an Important [...]
Powerful NeOnc Brain Cancer Pipeline Advances
28/09/2026
November 17 FDA Meeting Set to Discuss Dosing and Trial Size for Second Drug in Pipeline DENVER, Sept. 28, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NASDAQ: NTHI) is putting another [...]
Novo Nordisk A/S - share repurchase programme
28/09/2026
Bagsværd, Denmark, 28 September 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
Novonesis celebrates major expansion of West Allis production facility, strengthening North American dairy innovation and manufacturing
28/09/2026
Investment increases production capacity, supports booming consumer demand and reinforces Wisconsin's leadership in dairy biosolutions WEST ALLIS, Wis., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Novonesis , a global leader in [...]
MindRank Partners with 3SBio to Commercialize its AI-Designed Oral GLP-1 in China
28/09/2026
HANGZHOU, China, Sept. 28, 2026 (GLOBE NEWSWIRE) -- MindRank AI Ltd. ("MindRank") today announced that it has entered into a strategic commercialization agreement with Zhejiang Sunshine Mandi Pharmaceutical Co., Ltd. (" [...]
Oncolytics Biotech® Reports Accelerating Enrollment in Randomized REO 033 RAS-Mutant, MSS Colorectal Cancer Study
28/09/2026
Substantially all planned REO 033 clinical sites are now activated, with multiple patients currently on study Company expects to have sufficient Part A data to provide an interim clinical update by year-end 2026 FDA [...]
EnerSyn Global Inc. Announces Second Nigeria Energy Investment: Lagos CNG Mother Station Project
28/09/2026
BETHESDA, MD, Sept. 28, 2026 (GLOBE NEWSWIRE) -- EnerSyn Global Inc. (Nasdaq: ESYN) ("ESYN" or the "Company," and formerly known as HWH International Inc.) announced plans today to add a second energy project. On [...]
Hyperion DeFi Supports D3’s Frontier Vault Launch, Bringing Internet Domain Priority Access to the Hyperliquid Ecosystem
28/09/2026
DALLAS, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), today announced it has been named a launch partner for Frontier’s Hyperliquid Vault, a new membership [...]
CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus®
28/09/2026
AI-assisted reading tool designed to aid physician review of small bowel capsule endoscopy studies performed due to suspected bleeding using the CapsoCam Plus® system SARATOGA, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE [...]
Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026
28/09/2026
Oral presentation to highlight early endoscopic improvement and evidence of PDE4 target engagement in fibrostenotic Crohn’s disease Three moderated posters to showcase gut-targeted exposure, favorable safety and [...]
Lifecore Biomedical to be Acquired by Webster Equity Partners
28/09/2026
Lifecore Common Stockholders to Receive $6.28 per Share in Cash at Closing, Representing a 49.5% Premium Lifecore Series A Preferred Stockholders Will Receive Required “Conversion Amount” per Share in Cash at Closing [...]
Transactions under Novonesis’ share buyback program
28/09/2026
Please read the announcement in PDF Attachment 2026_19_Share_buyback
GRI Bio to Highlight Immune Modulation and Phase 2a Development Insights in IPF at the 10th IPF Summit
28/09/2026
Chief Executive Officer Marc Hertz and Chief Scientific Officer Vipin Kumar to present on translating immune biology and clinical signals into novel therapeutic approaches for IPF LA JOLLA, CA, Sept. 28, 2026 (GLOBE [...]
Carlsmed Appoints Richard Heppenstall as Chief Financial Officer
28/09/2026
Company Reaffirms Fiscal Year 2026 Guidance CARLSBAD, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled [...]
DLH Awarded New NIH Cybersecurity Operations Task Order Valued at Up to $19.1 Million
28/09/2026
ATLANTA, Sept. 28, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital, engineering, and scientific solutions for health and defense missions, today [...]
Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026
28/09/2026
SEATTLE and VANCOUVER, British Columbia, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and [...]
Silexion Therapeutics Reports Positive Preclinical Findings for SIL204, Demonstrating Key Mechanism for Endogenous Systemic Uptake in KRAS-Driven Cancers
28/09/2026
Translational research demonstrates that SIL204 utilizes native serum lipids to facilitate intracellular delivery and robust KRAS oncogene knockdown Findings validate that physiological lipoprotein levels are sufficient [...]

Pages